Rhythm Pharmaceuticals to Present at 2021 Canaccord Genuity 41st Annual Growth Conference

NEXT STORY
Novan to Report Second Quarter 2021 Financial Results on August 12, 2021
PREV STORY
Allergies in Primary Care: A Study of the Allergy Management Evaluation Tool Published on Consultant360 Specialty Network
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Taconic Biosciences Launches New Immuno-oncology Mouse Model

author_avatar
NASDAQ Market News

Intuitive Announces Second Quarter Earnings

author_avatar
NASDAQ Market News

Idera Pharmaceuticals Presents Clinical Data from the ILLUMINATE-204 Trial of the Combination of tilsotolimod and ipilimumab for Anti-PD-1 Refractory Metastatic Melanoma at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

- Data from Ongoing Phase 2 Study to be Presented at 1:15 PM CT ...

author_avatar
NASDAQ Market News